PROSIGHT MANAGEMENT, LP – Cue Biopharma, Inc. Transaction History
PROSIGHT MANAGEMENT, LP portfolio value:
$3.44M
portfolio value
PROSIGHT MANAGEMENT, LP quarter portfolio value change:
-10.44%
quarter
Cue Biopharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.64% | -109.90K shares | -675K | $2.23 | 1.54M |
| Q2 2022 | share | Increase | +9.61% | 145.19K shares | -3.24M | $2.49 | 1.65M |
| Q1 2022 | share | Increase | +82.17% | 681.24K shares | -2.00M | $4.88 | 1.51M |
| Q4 2021 | share | Increase | +26.54% | 173.85K shares | -170K | $11.4 | 829.04K |
| Q3 2021 | share | Increase | +3.94% | 24.82K shares | 2.20M | $14.57 | 655.18K |
| Q2 2021 | share | Increase | +13.22% | 73.58K shares | 551K | $11.65 | 630.36K |
| Q1 2021 | share | Decrease | -38.58% | -349.79K shares | -4.54M | $12.2 | 556.77K |
| Q4 2020 | share | Increase | +27.70% | 196.63K shares | 656K | $12.51 | 906.56K |
| Q3 2020 | share | Increase | +128.79% | 399.64K shares | 3.08M | $15.05 | 709.93K |
| Q2 2020 | share | Decrease | -43.79% | -241.76K shares | -229K | $24.51 | 310.29K |
| Q1 2020 | share | Increase | +301.12% | 414.43K shares | 5.64M | $14.19 | 552.06K |
| Q4 2019 | share | Increase | 0.00% | 137.62K shares | 2.18M | $15.88 | 137.62K |